Reference 37 2019
Xochelli A, Bikos V, Polychronidou E, Galigalidou C, Agathangelidis A, Charlotte F, Moschonas P, Davis Z, Colombo M, Roumelioti M, Sutton LA, Groenen P, van den Brand M, Boudjoghra M, Algara P, Traverse-Glehen A, Ferrer A, Stalika E, Karypidou M, Kanellis G, Kalpadakis C, Mollejo M, Pangalis G, Vlamos P, Amini RM, Pospisilova S, Gonzalez […]
Reference 21 2019
Brüggemann M, Kotrová M, Knecht H, Bartram J, Boudjogrha M, Bystry V, Fazio G, Froňková E, Giraud M, Grioni A, Hancock J, Herrmann D, Jiménez C, Krejci A, Moppett J, Reigl T, Salson M, Scheijen B, Schwarz M, Songia S, Svaton M, van Dongen JJM, Villarese P, Wakeman S, Wright G, Cazzaniga G, Davi F, […]
Reference 22 2019
Knecht H, Reigl T, Kotrová M, Appelt F, Stewart P, Bystry V, Krejci A, Grioni A, Pal K, Stranska K, Plevova K, Rijntjes J, Songia S, Svatoň M, Froňková E, Bartram J, Scheijen B, Herrmann D, García-Sanz R, Hancock J, Moppett J, van Dongen JJM, Cazzaniga G, Davi F, Groenen PJTA, Hummel M, Macintyre EA, […]
Reference 23 2019
Chartomatsidou E, Ntoufa S, Kotta K, Rovida A, Akritidou MA, Belloni D, Ferrero E, Trangas T, Stavroyianni N, Anagnostopoulos A, Rosenquist R, Ghia P, Papakonstantinou N, Stamatopoulos K. Inhibition of EZH2 and immune signaling exerts synergistic antitumor effects in chronic lymphocytic leukemia. Blood Adv. 2019 Jun 25;3(12):1891-1896. PMID: 31227476. doi: 10.1182/bloodadvances.2018030262.
Reference 24 2019
Kosalai ST, Morsy MHA, Papakonstantinou N, Mansouri L, Stavroyianni N, Kanduri C, Stamatopoulos K, Rosenquist R, Kanduri M. EZH2 upregulates the PI3K/AKT pathway through IGF1R and MYC in clinically aggressive chronic lymphocytic leukaemia. Epigenetics. 2019 Nov;14(11):1125-1140. Epub 2019 Jun 26. PMID: 31216925. doi: 10.1080/15592294.2019.1633867.
Reference 25 2019
Scheijen B, Meijers RWJ, Rijntjes J, van der Klift MY, Möbs M, Steinhilber J, Reigl T, van den Brand M, Kotrová M, Ritter JM, Catherwood MA, Stamatopoulos K, Brüggemann M, Davi F, Darzentas N, Pott C, Fend F, Hummel M, Langerak AW, Groenen PJTA; EuroClonality-NGS Working Group. Next-generation sequencing of immunoglobulin gene rearrangements for clonality […]
Reference 26 2019
Tsanousa A, Ntoufa S, Papakonstantinou N, Stamatopoulos K, Angelis L. Study of gene expressions’ correlation structures in subgroups of Chronic Lymphocytic Leukemia Patients. J Biomed Inform. 2019 Jul;95:103211. Epub 2019 May 18. PMID: 31108207. doi: 10.1016/j.jbi.2019.103211.
Reference 27 2019
Nalin M, Baroni I, Faiella G, Romano M, Matrisciano F, Gelenbe E, Martinez DM, Dumortier J, Natsiavas P, Votis K, Koutkias V, Tzovaras D, Clemente F: The European cross-border health data exchange roadmap: Case study in the Italian setting. J Biomed Inform. 2019 Jun;94:103183. PMID: 31009760. doi: https://dx.doi.org/10.1016/j.jbi.2019.103183
Reference 28 2019
Natsiavas P, Kakalou C, Votis K, Tzovaras D, Maglaveras N, Koutkias V: Requirements Elicitation for Secure and Interoperable Cross-Border Health Data Exchange: the KONFIDO Study. IET Software 2019;13(3):203-210. doi: https://doi.org/10.1049/iet-sen.2018.5292
Reference 29 2019
Natsiavas P, Jaulent MC, Koutkias V: A Knowledge-Based Platform for Assessing Potential Adverse Drug Reactions at the Point of Care: User Requirements and Design. Stud Health Technol Inform. 2019 Aug 21;264:1007-1011. PMID: 31438076. doi: https://dx.doi.org/10.3233/SHTI190376
